Details for New Drug Application (NDA): 209087
✉ Email this page to a colleague
The generic ingredient in BUPIVACAINE HYDROCHLORIDE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
Summary for 209087
Tradename: | BUPIVACAINE HYDROCHLORIDE |
Applicant: | B Braun Medical Inc |
Ingredient: | bupivacaine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 209087
Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 209087
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;SPINAL | 209087 | ANDA | B. Braun Medical Inc. | 0264-9379 | 0264-9379-88 | 10 AMPULE in 1 CARTON (0264-9379-88) / 2 mL in 1 AMPULE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;SPINAL | Strength | 0.75% | ||||
Approval Date: | Apr 2, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription